P3596Dabigatran, rivaroxaban, and apixaban versus vitamin K antagonists for atrial fibrillation patients at low to intermediate stroke risk: a Danish nationwide cohort study
Dukanovic, A., Staerk, L., Fosbol, E.L., Sindet-Pedersen, C., Bonde, A.N., Lorentzen, A.G., Gislason, G.H., Torp-Pedersen, C., Olesen, J.B.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article
549: LUNAR-CF: A novel mRNA therapeutic approach to correct the root cause of cystic fibrosis lung disease
Perez-Garcia, C., Pei, Y., Bao, Y., Karmali, P., Liu, X., Engelhardt, J., Hodges, C., Mense, M., Coote, K., Cheng, Y., Mahoney, J., Gonzalez, J., Dukanovic, A., Parker, S., Grossman, T., Geller, D., Chivukula, P.
Published in Journal of cystic fibrosis (01.11.2021)
Published in Journal of cystic fibrosis (01.11.2021)
Get full text
Journal Article